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ABSTRACT
Introduction Palliative and end- of- life care in care homes 
is often inadequate, despite high morbidity and mortality. 
Residents can experience uncontrolled symptoms, poor 
quality deaths and avoidable hospitalisations. Care home 
staff can feel unsupported to look after residents at the 
end of life. Approaches for improving end- of- life care are 
often education- focused, do not triage residents and rarely 
integrate clinical care. This study will adapt an evidence- 
based approach from Australia for the UK context called 
‘Palliative Care Needs Rounds’ (Needs Rounds). Needs 
Rounds combine triaging, anticipatory person- centred 
planning, case- based education and case- conferencing; 
the Australian studies found that Needs Rounds reduce 
length of stay in hospital, and improve dying in preferred 
place of care, and symptoms at the end of life.
Methods and analysis This implementation science 
study will codesign and implement a scalable UK model 
of Needs Rounds. The Integrated Promoting Action on 
Research Implementation in Health Services (i- PARIHS) 
framework will be used to identify contextual barriers and 
use facilitation to enable successful implementation. Six 
palliative care teams, working with 4–6 care homes each, 
will engage in two phases. In phase 1 (February 2021), 
stakeholder interviews (n=40) will be used to develop 
a programme theory to meet the primary outcome of 
identifying what works, for whom in what circumstances 
for UK Needs Rounds. Subsequently a workshop to 
codesign UK Needs Rounds will be run. Phase 2 (July 
2021) will implement the UK model for a year. Prospective 
data collection will focus on secondary outcomes 
regarding hospitalisations, residents’ quality of death 
and care home staff capability of adopting a palliative 
approach.
Ethics and dissemination Frenchay Research Ethics 
Committee (287447) approved the study. Findings will be 
disseminated to policy- makers, care home/palliative care 
practitioners, residents/relatives and academic audiences. 
An implementation package will be developed for 
practitioners to provide the tools and resources required to 
adopt UK Needs Rounds.
Registration details Registration details: 
ISRCTN15863801.
INTRODUCTION
Care home residents (hereafter referred to 
as residents) are an ageing population and 
are often frail with multiple complex health 
needs.1 2 Older people’s care homes in the 
UK experience high mortality rates, with 
between 26%3 and 56%1 of care home resi-
dents dying in the first year of admission. 
Care homes, including those with and without 
registered nurses (RNs), increasingly look 
after older people with complex multiple 
morbidities.4 Projections show that if current 
trends continue, care homes will be the most 
common place of death by 2040.5
Residents often experience inadequate 
end- of- life care as a result of avoidable hospi-
talisations,6 unmanaged symptoms, poor 
anticipatory/advance care planning7 and 
communication barriers.8 9 Staff report diffi-
culties with interdisciplinary working,10 and 
low confidence and capability7 in managing 
symptoms and identifying when people are 
dying, deficiencies exacerbated by workforce 
issues, including staff shortages, high turn-
over11 12 and time restrictions.13
Residents often have multiple admis-
sions to hospital prior to their death,6 with 
some admissions potentially preventable.14 
Strengths and limitations of this study
 ► Using implementation science will improve the 
chances of Needs Rounds being successfully imple-
mented across the sites.
 ► Data collection techniques will flexibly use video 
interviews and virtual workshops to accommodate 
lockdown and social distancing measures.
 ► Care home staff collection of resident data will pre-
vent the need for research staff to access personal 
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Hospitalisations are costly and may prompt futile inter-
ventions that can cause distress to residents and family 
members.15 Developing evidence- based approaches to 
support older people at the end of life, and reducing 
avoidable and often detrimental admissions to acute care, 
must therefore be a priority.
A systematic review of end- of- life care in UK care homes 
calls for the extension of specialist palliative care in care 
homes.10 Key issues reported include staff struggling to 
identify when residents are approaching end of life and 
unanticipated deterioration impacting decision- making 
about hospitalisations. Anticipatory/advance care plan-
ning training needs were also highlighted, with staff 
frequently avoiding these conversations due to lacking 
confidence and knowledge. The need to strengthen inter-
disciplinary working to address reactive decision- making 
and improve understanding about who is responsible for 
discussions about end- of- life care was also described.
Providing end of life support to care homes is a growing 
area of service development. Current approaches 
such as ECHO (Extension of Community Healthcare 
Outcomes),16 Gold Standard Framework (GSF),17 
Macmillan’s education for carers ‘Foundations in Pallia-
tive Care’, Six Steps to Success,18 PACE (Palliative Care 
Across Europe)19 and the Namaste programme20 offer 
staff training, yet rarely facilitate evidence- based clinical 
input for people diagnosed as dying. Both the GSF21 and 
PACE22 recommend monthly interdisciplinary meetings, 
although this is often variable in practice. Furthermore, 
such interventions often fail to change behaviour.23 24
This study aims to address recognised deficits in the 
provision of palliative and end- of- life care in care homes, 
by using an implementation science approach to alter 
practice and embed a promising approach developed in 
Australia called ‘Palliative Care Needs Rounds’ (Needs 
Rounds). Needs Rounds improve palliative and end- of- life 
care by reducing unnecessary hospitalisations, increasing 
staff knowledge and capability, improving anticipatory/
advance care planning and strengthening interagency 
working.
Intervention description
Needs Rounds are monthly hour- long triage meetings 
focused on 8–10 residents in each care home who are 
at risk of dying without a plan in place. A checklist25 is 
used to identify the most appropriate residents to discuss. 
Needs Rounds are chaired by a palliative care specialist 
and attended by care home staff who discuss each resi-
dent’s physiological, psychosocial and spiritual needs. 
This instigates a number of tailored actions, which are 
always personalised for the individual, including medica-
tion reviews, case conferences, anticipatory/advance care 
planning and referrals to relevant specialists.
Needs Rounds have a strong evidence base to support 
their uptake. Research in Australia demonstrated a 
number of positive outcomes. Needs Rounds reduced 
the length and number of hospitalisations,26 27 increased 
resident dying in their preferred place,26 with dignity, 
compassion and comfort,28 enabled staff to normalise 
death and dying,29 and improved workforce confidence.28
Aims and objectives
This study aims to codesign and implement an appro-
priate scalable UK model of Needs Rounds, which offers 
specialist palliative care outreach to care homes, in order 
to improve the lives and deaths of residents. The objec-
tives are:
Implementation
1. Codesign a UK version of Needs Rounds, which is re-
sponsive to the different (macro, meso and micro) 
contextual characteristics of the UK care home sector.
2. Implement the adapted model of care, assess feasi-
bility, acceptability and effectiveness, and ultimately 
propose how the model of care can be further refined 
and adopted in the UK context, to reap the benefits 
demonstrated in the Australian work.
Intervention
1. Determine the transferability of the core elements of 
the Needs Rounds intervention in a UK context.
2. Delineate the mechanisms of action that enable more 
effective palliative and end- of- life care practices to be 
realised in UK care homes.
3. Identify the relationships between (1) the mechanisms 
of action embedded in Needs Rounds, (2) how these 
mechanisms function in different care home contexts 
and (3) the outcomes arising for different stakehold-
ers and parts of the care system.
Process evaluation
1. Document the outcomes of UK Needs Rounds on hos-
pitalisations (including costs), quality of death/dying 
and staff capability.
2. Assess and report the perspectives of care home resi-
dents/relatives/staff and palliative care staff on using 
UK Needs Rounds.
3. Map the UK Needs Rounds fit for services not engaged 
in the implementation study.
4. Identify the outcomes, impact and experience of pa-
tient/public involvement (PPI) in the study.
METHODS AND ANALYSIS
This pragmatic critical- realist implementation study30 will 
use the Integrated Promoting Action on Research Imple-
mentation in Health Services (i- PARIHS) framework31 32 
in six case studies. Each case comprises a specialist pallia-
tive care team working with 4–6 care homes each.
i- PARIHS represents an integrated approach, recog-
nising that most implementation is complex, requiring 
attention to multiple factors simultaneously for an 
innovation to be successful. The development of theory 
is central to i- PAHRIS and enables effective implemen-
tation of research evidence into everyday practice.33 
Programme theories explaining micro changes and trans-
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change, are explored to elucidate core concepts. From 
these, mid- range theories are developed that have greater 
explanatory potential to predict and plan for change 
across different settings.33 For this study, theories will be 
generated regarding (1) influential components of the 
UK context and (2) the mechanisms of how to implement 
Needs Rounds in care homes in order to deliver desired 
outcomes.
Facilitation is also critical for successful implemen-
tation.31 Facilitators are agents of change who lead or 
champion an innovation. Facilitators for each case will be 
identified during phase 1 data collection.34 Recognising 
the likelihood of high turn- over of staff in care homes, at 
least two key staff members (facilitators) will be identified 
for each care home.
Target sites and population
Four case study sites will be in England and two in Scot-
land. Each site consists of a palliative care specialist service 
which will work with 4–6 care homes in their local area. 
Recruitment will be undertaken by the hospices with 
support from the research team and ENRICH (a national 
network for care home research) where necessary.
Purposive maximum variability sampling of specialist 
palliative care services will focus on recruiting a hetero-
geneous and information- rich sample to reflect, for 
example: urban/rural, service size, deprivation, cultural 
demographics, use of ECHO35 or other specialist 
palliative care input models, hospital at home services 
and care home support teams, national charity/indepen-
dent management, funding models, and hospital transfer 
policies. These variables reflect the dominant contextual 
influences which are likely to impact how Needs Rounds 
are used in the UK.
Table 1 provides a breakdown of the inclusion criteria 
for each participant group. The qualitative sample 
(n=40 interviewees) seeks adequate depth and breadth 
to determine the implementation objective: ‘what 
works for whom under what circumstances’. Interview 
sample sizes are based on the Australian studies, and are 
congruent with accepted standards for qualitative data 
interpretation.36
For the quantitative sample, the average size of the care 
homes is anticipated to be 52 beds, and the rate of emer-
gency admission to hospital to be 0.173 per bed within 
the 4- month period,37 with an average of 9 admissions 
per care home. A sample of 30 care homes would allow 
change to be identified in the hospitalisation rate of 0.02 
per bed (α=0.05, β=0.2, ΔSD=0.040). This is sufficient 
to detect a clinically meaningful change in the primary 
outcome (reduction of one hospitalisation per 4 month 
period in a typical care home) for the quantifiable data 
in phase 2.
Table 1 Sample and inclusion criteria
Participant Inclusion criteria
Stakeholders (phases 1 and 2 
interviews). n=40
1. Work for the specialist palliative care service or a care home (with or without registered 
nursing) in one of the six cases; or are a resident in one of the care homes; or are a 
relative of a care home resident in one of the six cases; or work in acute care impacted 
by hospitalised care home residents
2. Willing to provide informed consent
3. Have capacity to provide their own consent to participate
4. Not engaged in any current safeguarding investigations.
Care homes (adopting Needs 
Rounds as their new standard of 
care). n=28–36
1. Located near to the specialist palliative care team
2. Provide care to residents who have high clinical nursing/medical needs
3. Willing to sign a memorandum of understanding with the research team, outlining 
resident demographics and health service use data, facilitate access to staff for 
interviews, and engagement in Needs Rounds
4. A range of sizes (focusing primarily on larger care homes, following CQC data indicating 
lower quality in larger facilities),46 sole traders and large corporate provider, and with a 
range of funding models (NHS/social care and self- funded residents).
Residents (discussed at Needs 
Rounds in phase 2)
Estimate of n=1500
1. Resident in a collaborating care home in one of the six case study locations
2. An anticipated life- expectancy of less than 6 months
3. At risk of dying without appropriate planning in place
4. Experiencing inadequately managed bio- psychosocial symptoms
5. Not engaged in any current safeguarding investigations
6. Able to provide their own informed consent
Relatives (completing outcome 
measures in phase 2) n=300
1. The relative of a resident who was discussed in Needs Rounds
2. Able to provide their own informed consent.
PPI evaluation n=15 1. Coinvestigator or a member of one of the case study sites
2. Able to provide their own informed consent
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Project phases
Phase 1: codesigning Needs Rounds for the UK context
The purpose of phase 1 is to conduct theoretical model-
ling to generate programme theories about how Needs 
Rounds could be used. Programme theories will be devel-
oped by examining what elements of Needs Rounds would 
work, for whom, in what circumstances and why, in the UK 
context. Data will be collected through 40 semistructured 
individual or small- group interviews with key stakeholders 
from the six case study sites. Interviewees will be asked to 
describe their local context, such as services’ geography, 
policy, structure, funding and practice elements.
Contextual factors can significantly impact implemen-
tation; therefore, understanding and being responsive 
to these components are essential.34 Key contextual 
factors will be mapped out in the phase 1 interviews, 
drawing on the i- PAHRIS inner (micro and meso) and 
outer level (macro) contextual factors.38 The former 
includes individual and organisational components such 
as culture, leadership, experience of innovation, and 
absorptive capacity, while the latter examines the wider 
health system, including policy drivers, regulatory frame-
works, and interorganisational networks and relation-
ships. Services’ geography, policy, structure, funding and 
practice elements will then be refined in workshops to 
codesign Needs Rounds. Differences between the UK and 
Australia will be described.
Relevant documentation (eg, service policies) will be 
collated to help develop realist theories regarding how 
implementation would work in practice and what might 
influence implementation in each case study site, to 
identify contextual factors, mechanisms and outcomes 
(CMO) (figure 1).
Phase 2: implementing and evaluating Needs Rounds
Phase 2 will test and refine the programme theories 
generated in phase 1, by implementing, adapting and 
evaluating UK Needs Rounds in the six case study sites. 
Interviews will be conducted after 4 months (capturing 
early adoption), 8 months (mid- range) and 12 months 
(longer term) of implementation. Interviews will collect 
prospective data on process and mechanisms of change 
and examine the CMOs/theories, acceptability, appro-
priateness, feasibility, implementation cost, coverage, 
sustainability and adherence.
Phase 2 will also incorporate a qualitative evaluation 
of the impact, outcomes and process of PPI throughout 
the study. A survey will be conducted with care homes 
not engaged in the implementation after the phase 2 
workshop to garner feedback on the fit of the UK Needs 
Rounds approach for their service.
Key study phases are depicted in figure 2.
Outcomes
The primary outcome is to determine what works, for 
whom, in what circumstances, for UK Needs Rounds. 
Secondary outcomes focus on health service use, along-
side quality of death and dying, staff capability to adopt a 
palliative approach, and family perceptions of care. The 
core economic outcome is the total change in health and 
social care service costs that result from the intervention.
Data collection
Data will be collected for each case from interviews and 
site documentation. Activity logs will also be generated, 
to capture time spent by all parties, and additional work 
generated beyond the Needs Rounds meeting. Environ-
mental/contextual data will draw from conceptual work 
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by Estabrook et al39 and i- PARIHS34 38 and be qualitative in 
nature to dynamically explore each care home’s culture. 
Interview topics will cover, for example, provider and 
funding types, leadership, culture, including attitudes 
towards residents and whether staff feel supported and 
valued, time/space, staff/resident turnover, introduction 
of new policies/procedures, and prioritisation of the 
intervention in workload.
Needs Rounds discussions will be audio- recorded. This 
will allow analysis of adaptations made by clinical teams 
for their local areas, alongside the breadth/depth/
content of case- based education provided.
Staff capability of adopting a palliative approach (CAPA) 
will be assessed on a nine- item validated self- report ques-
tionnaire.40 CAPA has a unidimensional scale; higher 
scores indicate greater capacity. Internal consistency reli-
ability is very high with a Cronbach’s alpha of 0.95, and 
split- half- reliability coefficient of 0.93.40 Self- complete 
measures will be taken at baseline from all nursing assis-
tants/care assistants and RNs, and prospectively each 
month with staff attending Needs Rounds. Final assess-
ment will be taken from all NAs and RNs following the 
12- month trial period.
The Quality of Death and Dying Index41 (QODDI) will 
be completed by care home staff for each decedent resi-
dent prospectively during implementation. This 17- item 
questionnaire examines four domains: symptom control, 
preparation, connectedness and transcendence, on a 
0–10 scale, where higher scores indicate a better experi-
ence. The Cronbach’s alpha for the QODDI total score 
is 0.89. Following correspondence with the scale’s origi-
nator confirming psychometric robustness of excluding 
items, one item on access to euthanasia will be removed, 
as this is not legal in the UK. The QODDI was designed 
for completion by relatives; however, staff are more likely 
to have seen the resident in the weeks prior to death so 
staff completion will result in more reliable and valid data.
Family perceptions of care will be captured from rela-
tives of residents who are discussed at Needs Rounds, 
using the CANHELP lite.42 Twenty- two items from the 
second half of the questionniare will be used to collect 
family self- reported data of satisfaction with care. The 
Cronbach’s alpha for the total score is 0.88–0.94. A family 
will only be asked once to complete this measure, even 
if the resident is discussed at Needs Rounds more than 
once.
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Resident data collection will focus on demographic 
information and health service use (table 2). Data will 
be collected from the care homes by care home staff. 
Training will be provided to ensure robust data collection 
and reporting. This will be summary level data to ensure 
anonymity.
Economic evaluation will be based on the intervention 
and health service cost elements identified in tables 3 
and 4. The costs of hospitalisation will be constructed 
from resident- level data on length of stay collected by 
the care homes, and costed using the National Tariffs 
and hospital specific Patient Level Information and 
Costing System data for both England and Scotland. 
Total costs for the each of the pre and post periods will 
be calculated by summing these costs across all resi-
dents admitted to hospital from a given site; the benefit 
is the difference between prehealth and posthealth 
service- use costs.
Analysis
Fidelity will be assessed through analysis of a random 
sample of 20% of all audio- recorded Needs Rounds to 
assess adherence to the agreed approach developed 
in the workshops. A three- tier scoring system will be 
adopted, of 1 (high adherence), 2 (moderate), 3 (low), 
with operational definitions for these scores developed 
prospectively as UK Needs Rounds are developed.
Transcripts of audio data and documentary evidence 
will be stored and organised using NVivo. Within and 
between case analysis will be conducted inductively, 
drawing on process tracing and constant comparative 
methods, respectively. Differences between the Austra-
lian context and the UK will be surfaced to facilitate 
detailed reporting on the specificity of the UK model to 
the local context. i- PARIHS will also be used to structure 
the analysis, and deductive analysis employed to refine 
the CMO theories. Thematic analysis will underpin 
the analytic approach, and follow the five- step process 
outlined by Braun and Clarke.43
CAPA, QODDI and CANHELP will be analysed with 
t- tests and presented using descriptive statistics, with 
statistical significance level set at p 0.05.
Economic analysis: estimating the treatment effect of the 
intervention on health service outcomes
Data on the number and duration of hospitalisations for 
all care home residents will be captured for the 4 months 
prior to implementation, and in months 9–12 of delivery. 
This allows time for the intervention to be established and 
ensures that equivalent 4 month periods are compared 
with control for seasonality.
The treatment effect will be estimated as paired t- tests 
of the rate of hospitalisation, and number of hospital 
days, respectively. Multilevel regression modelling of the 
two outcome measures will be conducted, controlling for 
local area deprivation, sector of the care home, and other 
characteristics to describe the wider factors associated 
with the changes in the outcomes observed. A weighted 
least squares model of the outcomes will be estimated, 
with cases weighted by the number of beds in the care 
homes as a further robustness check. The estimates of the 
treatment effect will be used in the cost effectiveness anal-
ysis, incorporating the uncertainty of the estimates in the 
analysis.
Estimating the cost effectiveness of the intervention on health 
service outcomes
A cost–benefit analysis (CBA) of the intervention will be 
undertaken. The cost calculation will include both direct 
and indirect costs to both NHS and care homes delivering 
the intervention. Benefits are calculated as the change in 
NHS costs incurred following the intervention. This will 
be estimated by valuing the reduction in hospital stays 
and hospital days as a result of the intervention. These 
will be measured using hospital day rates and ambulance 
costs. Where possible, data will also be collected on addi-
tional costs, such as hospital transfers via taxi and primary 
care use.
The CBA will be conducted from the perspective of 
the NHS and Personal Social Services. The costs of the 
intervention will be compared with the changes in health 
service costs from reduced hospitalisation. The costs and 
benefits will be calculated taking account of (1) uncer-
tainty in the estimate of the treatment effect; (2) projected 
costs over a 5- year period; and (3) spatial variation in 
cost across jurisdictions. Wherever possible the analytical 
specification will follow that of the National Institute of 
Health and Care Excellence (NICE) Reference Case.44 
Table 2 Resident data collection
Type Variables
Demographic information  ► Age
 ► Ethnicity
 ► First language
 ► Charlson Comorbidity 
Index
Deaths  ► Number of deaths
 ► Preferred place of death
 ► Actual place of death
Health service use  ► Clinical role seen in 
primary care
 ► Hospital admissions:
 ► Name of hospital
 ► Duration of admission
 ► Specialty/ward
 ► Mode of transport to 
hospital
Assessments and interventions 
triggered by Needs Rounds
 ► Physical assessments
 ► Clinical investigations, 
for example, blood/urine 
tests
 ► Referrals to other NHS 
services
 ► Changes in medicines
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While there are also likely to be individual and broader 
societal benefits arising from the intervention, these are 
challenging to value in financial terms and beyond the 
scope of this economic evaluation. They will be explored 
through the qualitative data collection.
The net benefits of the intervention will be modelled 
over a 5- year period separately for care homes in (1) 
England and (2) Scotland, given the estimate of cost 
savings per care home bed and the total number of care 
home beds in each jurisdiction, and applying an annual 
discount rate. These predictions will be modelled at the 
point estimate for the treatment effect, and also for the 
upper and lower bounds of the 95% CI around the treat-
ment effect, to provide a range of plausible costs savings 
over 5 years incorporating the uncertainty in the main 
study.
The treatment effect will be estimated using a pre and 
post design. One limitation of this design is that aggre-
gate time trends can be a confounder. Attempts have 
been made to mitigate this by using multiple sites across 
the country, and by measuring the baseline and post- 
treatment outcomes at the same time of year. However, 
national- level time trends could explain part of the differ-
ences observed and this will be reflected on when inter-
preting the results.
The uncertainty of the estimated treatment effect will 
be represented in the cost effectiveness analysis. The 95% 
CIs from the estimated treatment effect will be used to 
calculate estimated cost effectiveness ranges, that is, the 
cost effectiveness will be reported at (1) the lower bound 
of the 95% CI; (2) the point estimate of the treatment 
effect; and (3) the upper bound of the 95% CI. Reporting 
a cost effectiveness range will allow the uncertainty in 
the treatment estimate in the cost effectiveness figures 
to be captured. Some subgroup analysis is likely to be 
conducted, for example, to examine cases focused on 
independent specialist palliative care teams, and public 
versus private care homes.
Patient and public involvement
The PPI approach is informed by the National Standards 
and INVOLVE45 guidelines and aims to ensure the study is 
focused on improving services for residents and families. 
The PPI representatives were involved from the outset 
Table 3 Intervention cost elements
Cost type Cost detail Measurement of costs
Direct 
costs
Intervention costs on- site:
 ► Staff time
 ► Travel
 ► Consumables and equipment
 ► Workshop costs
Included within the project budget and therefore directly 
recorded. Where appropriate additional detail will be 
collected directly from the care homes.
Additional NHS staff time attending care home
Additional prescriptions
Estimated in the SoECAT, with additional costs recorded 
by intervention staff as required.




Wider additional costs incurred by the care home, 
including:
 ► Changes in their staffing
 ► Changes to facilities (ie, use of rooms), or overheads 
as a result of hosting the intervention.
These changes, and their associated costs, will be 




Inconvenience to staff, residents, family and carers as a 
result of the intervention.
These will not be measured directly, but will be explored 
in the qualitative interviews.
Table 4 Health service cost elements
Cost type Cost detail Measurement of costs
Direct costs Costs of ambulance journeys Estimated from the 2019/20 National Tariff Payment System.47
Hospital stay cost Hospital- specific Patient Level Information and Costing System 
data for England48 and Scotland49 on stay costs by age and 
gender to estimate a day rate to use in the hospital costing.
Primary care usage Collected from care home sites in a proforma through interviews
Indirect costs Wider additional costs incurred by the care 
home, in connection with resident hospital 
admissions, including staffing, travel, 
equipment or facilities.
These costs will be collected from care homes in a proforma 
through the interviews
Intangible costs Inconvenience to residents and their 
family/carers arising from hospitalisation
These will not be measured directly, but will be explored in the 
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as coapplicants to ensure the research questions were 
informed by people with lived experience as informal 
carers of people receiving end- of- life care in care homes. 
To date, PPI members have informed the choice of family 
outcome measures42 (focusing on a measure which would 
be least burdensome and most meaningful to relatives), 
devised interview questions, recruiting the research fellow 
(RF), contributed to ethical approval documentation and 
attended the research ethics committee meeting.
PPI members will attend monthly investigator meet-
ings and provide advice on all aspects of the study. They 
will assist with refining recruitment processes (including 
recruiting family members to phase 1), participate in the 
workshops to coproduce Needs Rounds, data collection, 
and data analysis. The PPI members will also dissemi-
nate information about the study and its results through 
talks to local carers groups and social media (blogs and 
Twitter). As the project develops, other opportunities for 
engagement and leadership will be discussed, and PPI 
members can take on roles which interest them. Bespoke 
training will be provided to meet any identified needs.
The PPI work will be evaluated throughout and a 
summative document will be produced at the end of the 
study. This will include PPI experiences and processes, 
an audit of PPI resources/costs, and evidence of impact. 
Interviews will be conducted with PPI members and the 
research team, including all coinvestigators and repre-
sentatives from the case study sites. These will examine 
successes and opportunities to enhance future PPI work. 
This is likely to be conducted by the study RF, presenting 
some limitations with objectivity and an independent 
RF will be used if possible. If sufficient capacity, then a 
researcher external to the study team will be engaged to 
increase potential for participants to speak openly about 
deficits to strengthen the PPI approach.
Ethics and dissemination
Ethical approval has been granted by the Frenchay 
REC (287 447) for the implementation study. Separate 
approval will be sought for the care home survey in 2022.
Participants (table 1) will be provided with a participant 
information sheet (PIS), including an easy read version 
for residents. Informed consent will be taken for partic-
ipation in interviews, questionnaires and Needs Rounds 
recordings. Care home staff will assess resident capacity 
and only those who are able to provide informed consent 
will be included in interviews. Informed consent will not 
be required for resident data as this will be summary data 
to ensure anonymity.
Given the sensitive nature of the research, participants 
may experience distress, particularly residents and rela-
tives. However, the PIS clearly outlines the nature and 
scope of the study; therefore all participants will be aware 
of the themes likely to be discussed. Furthermore, the 
topic guide and questionnaires have been examined by 
our PPI representatives for appropriateness.
The findings will be disseminated to policy- makers, care 
home/palliative care practitioners, care home residents/
relatives and academic audiences. Infographics, blogs, 
policy briefings and talks at carer groups/conferences will 
all be used. An implementation package will be developed 
for practitioners that provides all the tools and resources 
required to adopt UK Needs Rounds. The data will be 
deposited in the open access repository ‘DataSTORRE’.
Study management and sponsorship
A project steering group will oversee the study. It is chaired 
by an academic with expertise in care home research 
and has membership from individuals with expertise in 
implementation science, health economics, healthcare 
commissioning, palliative care and PPI.
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